Therefore, LMVECs treated with SSc or healthy sera were analyzed for gene and protein expression levels of the pro-lymphangiogenic receptor VEGFR-3/Flt-4 and its co-receptor NRP-2 [14,30]. Here, NRP2 is linked to systemic sclerosis.